Tara Santora is a former intern at Spectrum and a freelance journalist based in New York City. Tara has written about health and the environment for publications such as Psychology Today and Audubon magazine. They are also a graduate student at New York University’s Science, Health & Environmental Reporting Program.
Tara Santora
From this contributor
U.S. authorizes rapid blood test for fragile X syndrome
A new blood test can identify within seven hours whether a person carries the genetic mutation underlying fragile X syndrome.
U.S. authorizes rapid blood test for fragile X syndrome
New analysis of brain activity could identify signal for autism
A new technique allows researchers to analyze raw data across multiple studies that use electroencephalography.
New analysis of brain activity could identify signal for autism
Machine learning flags ‘mosaic’ mutations that may contribute to autism
A new technique detects rare mutations that occur in only a subset of the body's cells.
Machine learning flags ‘mosaic’ mutations that may contribute to autism
Smart jumpsuit may help test motor skills in infants with autism
A new jumpsuit is fitted with sensors that can track and classify an infant's posture and movements.
Smart jumpsuit may help test motor skills in infants with autism
Artificial neurons may repair damaged cells and circuits
Electronic neurons made from silicon mimic brain cells and could be used to treat conditions such as autism.
Artificial neurons may repair damaged cells and circuits
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.